Fig. 2From: Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasisCandidate driving genetic alterations and their druggability in AYA cancers. An analysis of WES/WTS and OncoScanâ„¢ with our heuristic annotation identified level-1 candidate genetic alterations. By analyzing DAVID and DGIdb, the representative pathway of AYA cancers and druggability were also identified. The druggability is indicated by illustrations of pills; red indicates a direct inhibitor of a candidate target gene, and blue/yellow indicates an inhibitor of a pathway that includes the candidate alterations. AYA07 was excluded from the candidate gene search due to the hypermutation. All candidate genetic alterations are described in Additional file 4: Table S3Back to article page